Treatment

Systemic Therapy for Stage IV Non-Small Cell Lung Cancer

August 31, 2015

Introduction

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) developed evidence-based recommendations for the treatment of stage IV non-small cell lung cancer (NSCLC). This is lung cancer that has spread to other parts of the body. This guide for patients contains several recommendations updated in 2015 to reflect new research and treatment options.

Radiation Therapy After Surgery for Endometrial Cancer

July 6, 2015

To help doctors provide their patients with the highest quality care, the American Society of Clinical Oncology (ASCO) issued an endorsement of a guideline developed in 2014 by the American Society for Radiation Oncology (ASTRO). This guideline provides recommendations for using radiation therapy after surgery for endometrial cancer.

Understanding endometrial cancer

Endometrial cancer is a type of cancer that starts in a woman’s uterus. The uterus has three sections:

  • The narrow, lower portion called the cervix

Treatment of Metastatic Castration-Resistant Prostate Cancer

September 8, 2014

Introduction

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO), along with Cancer Care Ontario, has developed recommendations on systemic, or full-body, treatments for men with metastatic castration-resistant prostate cancer. This guide for patients and caregivers is based on ASCO recommendations.

Key Messages:

Treatment of Advanced HER2-Negative Breast Cancer

September 2, 2014

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop evidence-based recommendations about specific topics in cancer care. These recommendations are for the treatment of human epidermal receptor 2 (HER2)-negative breast cancer that has spread beyond the breast to areas either nearby the breast or to distant parts of the body. This guide for patients and caregivers is based on ASCO's recommendations.

Key Messages:

Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

May 27, 2014

Introduction

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) developed evidence-based recommendations about hormonal therapy for early-stage breast cancer. This guideline has been updated several times since the original version in 2002. The latest update provides additional guidance on how long women can take tamoxifen (Nolvadex, Soltamox). This guide for patients is based on the most recent recommendations.

Key Messages:

Treatment of Metastatic HER2-Positive Breast Cancer

May 5, 2014

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop evidence-based recommendations about specific topics in cancer care. These recommendations are for the treatment of human epidermal receptor 2 (HER2)-positive breast cancer that has spread beyond the breast. This guide for patients and caregivers is based on ASCO's recommendations.

Key Messages:

Pages

Subscribe to RSS - Treatment